The U.K. NorthStar Clinical Network
- Sponsor
- University College, London
- Study ID
- NCT06711692
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- N/A - 99 Years
- Healthy Volunteers
- Not accepted
Study Details
The goal of this natural history study is to capture the natural history of Duchenne Muscular Dystrophy (DMD) in children and adults in the United Kingdom. Children and adults with DMD will be invited to join. The primary objective of the study is to collect longitudinal data on motor and respiratory function in DMD patients from childhood to adulthood. The secondary objectives of the study include collection of longitudinal data on other aspects of natural history on DMD, including respiratory, cardiac and endocrine complications, neurodiversity (cognitive impairment, neuro-behavioural disorders such as ADHD and autism), changes to bone density and occurrence of fractures, changes to puberty, incidence of scoliosis, unplanned hospital admissions, and quality of life. The study will also collect information on ethnicity. Participants will attend an annual or bi-annual neuromuscular clinic, and will have a series of assessments and questionnaires with the study team. These include: key medical data, physiotherapy data, respiratory assessments, Quality of Life questionnaires, and DMD questionnaires. Following assessments and questionnaire completion, data is input into the study's tailor-made National Neuromuscular Database.
Key Dates
- Start date
- Dec 1, 2024
- Status verified
- Nov 2024
- Primary completion
- Apr 30, 2025
- Completion
- Jun 30, 2025
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: DMD children and adultPaediatric and adults with DMD
Primary Outcome Measure
Longitudinal data on motor function in Duchenne Muscular Dystrophy (DMD) patients from the childhood to the adult phases of life [ Time Frame: From enrolment to the end of the study, across 18 months ]
Central Contacts
- Dr Adnan Manzur, FRCPCH+44 20 7405 9200
- Study Inbox
Related Studies
- Magnetic Resonance Imaging and Biomarkers for Muscular DystrophyRecruiting · University of Florida · Gainesville, Florida
- The Duchenne RegistryRecruiting · The Duchenne Registry · Washington D.C., District of Columbia
- Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability StudyPHASE2/PHASE3 · Recruiting · Italfarmaco · Sacramento, California
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina